LGC BIOSEARCH Webinars
| Lerna Biopharma’s liver regeneration story |
Abstract
In this webinar, Dr Torsten Wuestefeld, Co-founder and Advisor at Lerna Biopharma and Dr. Si Hui Tan, Vice President of Biology at Lerna Biopharma, talk about how they are combining novel biology with proprietary nucleic acid technology and delivery platforms to innovate and accelerate therapeutic development for liver diseases with high unmet need.
Key learning outcomes:
- Discover how levering siRNA can help deliver breakthrough drugs for diseases with unmet needs
- Learn why siRNA is the modality of choice for pursuing novel biology to generate first-in-class drugs
- Hear about design and synthesis of siRNA molecules
- Learn about developing siRNA drug candidates with technologies and platforms that address the challenges in the siRNA therapeutics development process
Speakers
Dr Torsten Wuestefeld
Co-founder and Advisor
Lerna Biopharma
Dr Si Hui Tan
Co-founder and Advisor
Lerna Biopharma